Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Better Buy: Biogen vs. Amgen


If you only picked which stocks to buy based on performance in recent years, Amgen (NASDAQ: AMGN) would be the hands-down winner over Biogen (NASDAQ: BIIB). Amgen has delivered higher gains than Biogen over the last year, three years, and five years.

But there0's a lot more to consider when investing in biotech stocks than just recent performance. The companies' product lineups and pipelines are much more important. Here's a quick rundown of what you need to know to choose between Biogen and Amgen.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Teilen

Kommentare